Case management of a multidrug-resistant Shigella dysenteriae serotype 1 outbreak in a crisis context in Sierra Leone, 1999-2000

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 11, 2004, Pages 635-643

  Guerin, Philippe J ^a,b,f   Brasher, Christopher ^c   Baron, Emmanuel ^c   Mic, Daniel ^c   Grimont, F ^d   Ryan, M ^e   Aavitsland, Preben ^b   Legros, Dominique ^a  

^a EPICENTRE   (France)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d INSTITUT PASTEUR   (France)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f EPIET   (Sweden)

Author keywords

Antibiotic resistance; Ciprofloxacin; Dysentery; Fluoroquinolones; Shigella dysenteriae; Sierra Leone

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; OFLOXACIN; ORAL REHYDRATION SOLUTION; SHIGELLA VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; DEATH; DISEASE SEVERITY; DRUG DOSE REGIMEN; EPIDEMIC; FATALITY; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT CARE; PATIENT EDUCATION; PERSONAL HYGIENE; SEROTYPE; SHIGELLA DYSENTERIAE; SHIGELLOSIS; SIERRA LEONE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DISEASE OUTBREAKS; DRUG RESISTANCE; DYSENTERY, BACILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTYPING; SEX DISTRIBUTION; SHIGELLA DYSENTERIAE; SIERRA LEONE;

SHIGELLA DYSENTERIAE;

EID: 11144271170     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2004.01.005     Document Type: Article

References (51)

1. Alghasham A.A. Nahata M.C. Clinical use of fluoroquinolones in children Ann. Pharmacother. 34 2000 347-359
2. Anh N.T. Cam P.D. Dalsgaard A. Antimicrobial resistance of Shigella spp. isolated from diarrheal patients between 1989 and 1998 in Vietnam Southeast Asian J. Trop. Med. Public Health. 32 2001 856-862
3. Aragon M. Barreto A. Chambule J. Noya A. Tallarico M. Shigellosis in Mozambique: The 1993 outbreak rehabilitation - a follow-up study Trop. Doct. 25 1995 159-162
4. Bastian S. Carle I. Grimont F. Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Eschericha coli Res. Microbiol. 149 1998 457-472
5. Bennish M.L. Wojtyniak B.J. Mortality due to shigellosis: Community and hospital data Rev. Infect. Dis. 13 Suppl 4 1991 S245-S251
6. Bethell D.B. Hien T.T. Phi L.T. Day N.P. Vinh H. Duong N.M. Len N.V. Chuong L.V. White N.J. Effects on growth of single short courses of fluoroquinolones Arch. Dis. Child. 74 1996 44-46
7. Bhattacharya K. Bhattacharya M.K. Dutta D. Dutta S. Deb M. Deb A. Das K.P. Koley H. Nair G.B. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children Acta Paediatr. 86 1997 319-320
8. Biedenbach D.J. Schermer I.H. Jones R.N. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices Diagn. Microbiol. Infect. Dis. 27 1997 1-5
9. Chopra M. Wilkinson D. Stirling S. Epidemic shigella dysentery in children in northern KwaZulu-Natal S. Afr. Med. J. 87 1997 48-51
10. Dalton C.B. Mintz E.D. Wells J.G. Bopp C.A. Tauxe R.V. Outbreaks of enterotoxigenic Escherichia coli infection in American adults: a clinical and epidemiologic profile Epidemiol. Infect. 123 1999 9-16
11. Diallo A. Diop M.B. Gueye M.M. Etard J.F. Investigation d'une épidémie de shigellose en zone rurale au Senegal Sante 11 2001 217-219
12. Dysentery Study Group: Zimbabwe, Bangladesh, South Africa (Zimbasa), 2002. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Pediatr. Infect. Dis. J. 21, 1136-1141
13. Ewing W.H. 1986. The genus Shigella, In: Ewing, W., Edwards, P.R. (Eds.), Edwards and Ewing's Identification of Enterobacteriaceae, fourth ed., Elsevier Publishing Co., New York, pp. 135-17
14. Goma Epidemiology Group 1995. Public health impact of Rwandan refugee crisis: What happened in Goma, Zaire, in July, 1994? Lancet 345, 339-344
15. Guerin P.J. Brasher C. Baron E. Mic D. Grimont F. Aavitsland P. Legros D. Shigella dysenteriae serotype 1 in west Africa: Intervention strategy for an outbreak in Sierra Leone Lancet 362 2003 705-706
16. Hooper D.C. Mechanisms of action and resistance of older and newer fluoroquinolones Clin. Infect. Dis. 31 Suppl 2 2000 S24-S28
17. Horiuchi S. Inagaki Y. Yamamoto N. Okamura N. Imagawa Y. Nakaya R. Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones Antimicrob. Agents Chemother. 37 1993 2486-2489
18. Huskins W.C. Griffiths J.K. Faruque A.S. Bennish M.L. Shigellosis in neonates and young infants J. Pediatr. 125 1994 14-22
19. Iversen E.R. Colding H. Petersen L. Ngetich R. Shanks G.D. Epidemic Shigella dysenteriae in Mumias, western Kenya Trans. R. Soc. Trop. Med. Hyg. 92 1998 30-31
20. Karch H. Bielaszewska M. Bitzan M. Schmidt H. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections Diagn. Microbiol. Infect. Dis. 34 1999 229-243
21. Keusch G.T. Bennish M.L. 1998. Shigellosis, In: Evans, A.S., Brachman, P.S. (Eds.), Bacterial infections of humans. Epidemiology and control, third ed., Plenum Medical Book Company, New York and London, pp. 631-656
22. Kotloff K.L. Winickoff J.P. Ivanoff B. Clemens J.D. Swerdlow D.L. Sansonetti P.J. Adak G.K. Levine M.M. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies Bull. World Health Organ. 77 1999 651-666
23. Laureillard D. Paquet C. Malvy D. Ciprofloxacine dans le traitement de la dysenterie à Shigella dysenteriae de type 1 lors d'une épidémie chez les réfugiés Rwandais à Goma en 1994 Sante 8 1998 303-305
24. Legros D. Paquet C. Dorlencourt F. Saoult E. Risk factors for death in hospitalized dysentery patients in Rwanda Trop. Med. Int. Health 4 1999 428-432
25. Leibovitz E. Janco J. Piglansky L. Press J. Yagupsky P. Reinhart H. Yaniv I. Dagan R. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children Pediatr. Infect. Dis. J. 19 2000 1060-1067
26. Malakooti M.A. Alaii J. Shanks G.D. Phillips-Howard P.A. Epidemic dysentery in western Kenya Trans. R. Soc. Trop. Med. Hyg. 91 1997 541-543
27. Murphy O. Fairbairn C. Stewart D. Freeman R. Etest evaluation of enterobacteriaceae with reduced susceptibility to ciprofloxacin J. Antimicrob. Chemother. 39 1997 551-552
28. Nathoo K.J. Porteous J.E. Siziya S. Wellington M. Mason E. Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe Cent. Afr. J. Med. 44 1998 272-276
29. Paquet C. Leborgne P. Sasse A. Varaine F. Une épidémie de dysenterie à Shigella dysenteriae type 1 dans un camp de réfugiés au Rwanda Sante. 5 1995 181-184
30. Pillay D.G. Karas A.J. Sturm A.W. An outbreak of Shiga bacillus dysentery in KwaZulu/Natal, South Africa J. Infect. 34 1997 107-111
31. Pitman C. Amali R. Kanyerere H. Siyasiya A. Phiri S. Phiri A. Chakanika I. Kampondeni S. Chintolo F.E. Kachenje E. Squire S.B. Bloody diarrhoea of adults in Malawi: Clinical features, infectious agents, and antimicrobial sensitivities Trans. R. Soc. Trop. Med. Hyg. 90 1996 284-287
32. Radice M. Gonzealez C. Power P. Vidal M.C. Gutkind G. Third-generation cephalosporin resistance in Shigella sonnei, Argentina Emerging Infect. Dis. 7 2001 442-443
33. Rahman M. Mauff G. Levy J. Couturier M. Pulverer G. Glasdorff N. Butzler J.P. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR Antimicrob. Agents Chemother. 38 1994 2488-2491
34. Ries A.A. Wells J.G. Olivola D. Ntakibirora M. Nyandwi S. Ntibakivayo M. Ivey C.B. Greene K.D. Tenover F.C. Wahlquist S.P. Griffin P.M. Tauxe R.V. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention J. Infect. Dis. 169 1994 1035-1041
35. Rollins N.C. Wittenberg D.F. Coovadia H.M. Pillay D.G. Karas A.J. Sturm A.W. Epidemic Shigella dysenteriae type 1 in Natal J. Trop. Pediatr. 41 1995 281-284
36. Salam M.A. Bennish M.L. Antimicrobial therapy for shigellosis Rev. Infect. Dis. 13 Suppl 4 1991 S332-S341
37. Salam M.A. Dhar U. Khan W.A. Bennish M.L. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis Lancet 352 1998 522-527
38. Sarkar K. Ghosh S. Niyogi S.K. Bhattacharya S.K. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones Lancet 361 2003 785
39. Schaad U.B. Use of the quinolones in paediatrics Drugs 45 Suppl. 3 1993 37-41
40. Shears P. Shigella infections Ann. Trop. Med. Parasitol. 90 1996 105-114
41. Tupasi T.E. Quinolone use in the developing world: State of the art Drugs 58 Suppl. 2 1999 55-59
42. Tuttle J. Tauxe R.V. Antimicrobial-resistant Shigella - the growing need for prevention strategies Infectious Diseases in Clinical Practice 2 1993 55-59
43. Tuttle J. Ries A.A. Chimba R.M. Perera C.U. Bean N.H. Griffin P.M. Antimicrobial-resistant epidemic Shigella dysenteriae type 1 in Zambia: Modes of transmission J. Infect. Dis. 171 1995 371-375
44. UNICEF United Nations Children's Fund, 2000. Statistical data: Sierra Leone. Available from: URL: http://www.unicef.org/statis/index.html
45. Vinh H. Wain J. Chinh M.T. Tam C.T. Trang P.T. Nga D. Echeverria P. Diep T.S. White N.J. Parry C.M. Treatment of bacillary dysentery in Vietnamese children: Two doses of ofloxacin versus 5-days nalidixic acid Trans. R. Soc. Trop. Med. Hyg. 94 2000 323-326
46. Wittenberg D.F. The spread of Shigella dysenteriae type I in Africa Jpn. J. Med. Sci. Biol. 51 1998 S36-S42
47. Wittenberg D.F. Emerging and re-emerging diseases - epidemic enterohaemorrhagic infections 100 years after Shiga S. Afr. Med. J. 89 1999 750-752
48. WHO 1995. Guidelines for the control of epidemics due to Shigella dysenteriae type 1. World Health Organization, Geneva, WHO/CDR/95.4
49. WHO 1997. Epidemic diarrhoeal disease preparedness and response. World Health Organization, Geneva, WHO/EMC/DIS/97.3
50. WHO 2000. The World Health Report 2000. World Health Organization, Geneva
51. WHO 2003. First steps for managing an outbreak of acute diarrhoea. World Health Organization, Geneva, WHO/CDS/CSR/NCS/2003.7